L-methionine
Amino has introduced L-methionine amino acid as a safe and effective active pharmaceutical ingredient (API) and nutritional substance.
Amino produces pharmaceutical-grade L-methionine in its state-of-the-art facility in Frellstedt, Germany, deriving the crude material from modern biotechnological methods, not through chemical synthesis. The entire L-methionine manufacturing process is free of animal-derived material and does not use solvents at any point.
“We perform quality assurance at every step of production, we comply with current good manufacturing practices (cGMPs) and we meet global pharmaceutical standards for APIs,” said Laura Schild, Marketing & Sales, Amino. “These procedures all ensure we always deliver absolutely pure and highly effective products.”
L-methionine is a sulfur-containing essential proteinogenic amino acid. The human body is not able to synthesise L-methionine by itself so has to be taken in in sufficient quantities from external sources. L-methionine plays a key role in many metabolic processes in the human body. Therefore it is an essential component of many pharmaceutical and nutraceutical products that contribute to restoring and preserving human health.
Given its role in metabolism, L-methionine is used in:
• total parenteral nutrition (TPN),
• special dietary products, especially nutrition for metabolic disorders
• pharmaceuticals and
• cell culture media.
Amino pharmaceutical grade L-methionine meets the highest quality standards and the requirements of such international pharmacopoeias as United States Pharmacopoeia (USP) and European Pharmacopoeia (Ph. Eur.)
Amino holds a US drug master file (DMF) and has applied for a European Certificate of Suitability (CEP) for L-methionine. The product is allergen-free and is Halal and Kosher certified.